Ionic Global Building Clinical Partnerships Through Science, Innovation and Education Malaysia’s economy continues to demonstrate resilience amid a changing global environment. According to Bank Negara Malaysia Governor Datuk Seri Abdul Rasheed Ghaffour, the country remains on track to achieve real gross domestic product growth of between 4% and 5% in 2026, with growth likely to be towards the upper end of the official forecast range and inflation expected to remain manageable. This positive assessment provides an encouraging signal for Malaysian businesses, investors and communities. Although global uncertainties—including energy supply pressures, geopolitical developments and changing trade conditions—may continue to influence the operating environment, Malaysia’s underlying economic fundamentals and domestic growth momentum remain supportive. For the healthcare and medical technology sectors, a firm economic outlook is particularly meaningful. Economic resilience can support continued investment in healthcare infrastructure, local manufacturing, research and development, professional education and community health programmes. It also creates opportunities for Malaysian companies to strengthen their capabilities and contribute more meaningfully to national healthcare security. Healthcare Innovation as Part of Malaysia’s Economic Progress Healthcare is more than an essential public service. It is also an important economic sector encompassing research, medical technology, manufacturing, regulatory development, professional services, distribution and community care. As healthcare requirements become increasingly complex, Malaysia needs solutions that are effective, accessible and suitable for local needs. Developing homegrown healthcare technology can help strengthen supply-chain resilience, reduce dependence on external sources and build valuable technical expertise within the country. Local manufacturers are also better positioned to work closely with Malaysian healthcare professionals, understand community needs and adapt solutions for different clinical, personal-care and public-hygiene environments. This is where companies such as Ionic Global Sdn. Bhd. can contribute—not only as manufacturers, but as healthcare technology partners committed to scientific development, responsible production and practical community applications. Ionic Global: A Malaysian Healthcare Technology Company Established in Malaysia, Ionic Global focuses on antimicrobial innovation through its proprietary IGTECH® Ionized and Electrolyzed Technology. Through a precisely controlled electrolysis process, IGTECH® produces high-purity hypochlorous acid, commonly known as HOCl, using water, salt and electricity. HOCl is a naturally occurring antimicrobial substance that is also produced by the human immune system as part of the body’s defence against harmful microorganisms. Ionic Global’s approach is centred on achieving an appropriate balance between antimicrobial performance, user safety, product stability and environmental responsibility. Its technology supports applications across wound management, personal hygiene, baby care, feminine and men’s care, pet care, environmental hygiene and specialised industry settings. By transforming electrolyzed science into practical products, Ionic Global seeks to make advanced antimicrobial technology more accessible to healthcare professionals, families, caregivers, businesses and communities. Antaviro™ Wound Care: Supporting Better Wound-Management Practices One of Ionic Global’s principal healthcare solutions is Antaviro™ Wound Care, developed to support wound cleansing and management. Effective wound care is important not only in hospitals and clinics but also in community healthcare. Patients living with chronic wounds, diabetic ulcers, post-procedure wounds and other difficult-to-manage conditions may require consistent care over an extended period. These conditions can affect mobility, quality of life, family responsibilities and healthcare costs. Antaviro™ Wound Care is formulated using Ionic Global’s electrolyzed HOCl technology. It is designed to help cleanse wounds, manage the wound environment and address microorganisms and biofilm that may interfere with recovery. Beyond supplying a product, Ionic Global supports the advancement of wound-care knowledge through engagement with healthcare professionals, clinical collaboration, professional education and real-world case observations. Such collaboration is essential because meaningful healthcare innovation must be guided by clinical needs and responsible use. Antaviro™ Wound Care’s listing in the MIMS Drug Reference Malaysia in March 2026 also represents an important milestone in strengthening its visibility among healthcare professionals. Through continued clinical engagement, Ionic Global aims to support better access to Malaysian-developed wound-care technology while building confidence in homegrown healthcare solutions. Ombac+™: Extending Hygiene Protection into Everyday Life Community well-being also depends on effective daily hygiene. The Ombac+™ range translates Ionic Global’s antimicrobial technology into solutions for individuals, families, pets, homes, workplaces and specialised environments. The range includes: Ombac+ Instant Hygiene Spray, an alcohol-free option for convenient personal hygiene. Ombac+ Feminine Hygiene Care and Men Hygiene Care, developed for gentle personal-care applications. Ombac+ Baby Instant Hygiene, formulated for the hygiene needs of babies and young children. Ombac+ Fur-Fur Spray and Fur-Fur Comfort, created to support pet hygiene and cleaner shared environments for animals and their families. Ombac+ Ultron and Air Guard, developed for environmental and surface-hygiene applications. Ombac+ MediFarm A-13, designed for animal-care and farm-hygiene settings. This broad range reflects an important principle: community health is not confined to hospitals. It begins in everyday environments—including homes, childcare settings, workplaces, animal-care facilities and public spaces. By offering alcohol-free and application-specific hygiene alternatives, Ionic Global seeks to make routine antimicrobial protection more practical for different members of the community. S’yatira™: Inclusive Personal Care for Community Needs Ionic Global’s commitment to inclusive care is further expressed through S’yatira™, a personal-care range developed with the hygiene and lifestyle needs of Muslim consumers in mind. The range includes female personal care, feminine care, scalp care, men’s care and baby hygiene applications. Its purpose is to provide products that are effective, gentle and aligned with the practical preferences of the communities they serve. Malaysia’s multicultural society requires companies to understand that healthcare and personal care are closely connected with culture, faith, dignity and individual comfort. Developing inclusive solutions is therefore not simply a market opportunity—it is part of responsible community engagement. Contributing Beyond Products Ionic Global believes that the value of healthcare technology should ultimately be measured by its contribution to people. For this reason, the company’s role extends beyond research, manufacturing and product distribution. Ionic Global continues to participate in healthcare education, professional engagement and community initiatives that promote safer hygiene and better care practices. These efforts include sharing wound-care knowledge with healthcare professionals, supporting community health activities, contributing hygiene solutions to family and children’s programmes and promoting responsible pet-care awareness. For example, Ionic Global supported the Little Dreamers Music Festival 2026 with Ombac+ Baby Instant Hygiene,

Latest COVID-19 Variant Update: Staying Informed, Staying Protected As the global health landscape continues to evolve, a new COVID-19 subvariant, BA.3.2—informally referred to as “Cicada”—is currently under observation across multiple countries. As part of the Omicron family, this subvariant reflects the natural progression of viral mutations, with early indications suggesting it may spread more easily and exhibit partial immune escape. Despite these developments, current data provides reassurance. There is no clear evidence that BA.3.2 leads to more severe illness. Reported symptoms remain consistent with earlier Omicron variants, including sore throat, cough, fever, and fatigue. Importantly, vaccination continues to play a critical role in reducing the risk of severe outcomes and hospitalisation. The emergence of new variants highlights the importance of sustained public awareness and everyday protective practices. Maintaining good hygiene, especially in shared and high-contact environments, remains a key line of defence in reducing transmission. In this context, Ionic Global Sdn Bhd continues to support community health through safe and effective hygiene solutions. Powered by advanced HOCl technology, products such as Ombac+ Instant Hygiene Spray and Ombac+ Ultron provide reliable antimicrobial protection for both personal use and surface disinfection. Their non-toxic and gentle formulation allows for frequent use, making them suitable for daily protection in homes, workplaces, and public spaces. As we adapt to an endemic environment, the focus shifts from fear to preparedness. Staying informed, practicing consistent hygiene, and leveraging safe, science-backed solutions are essential steps toward safeguarding individual and community well-being. Together, through awareness and responsible action, we can continue to navigate these changes with confidence and resilience. Source: New COVID variant “Cicada” spreads across US – key facts and symptoms

HOCl Market Growth& Industry Outlook (2025–2034) According to Fortune Business Insights in its Hypochlorous Acid Market Report (2025), the global HOCl market was valued at approximately USD 1.90 billion in 2025 and is projected to reach USD 3.32 billion by 2034, growing at a CAGR of 6.4%. Asia Pacific led the market in 2025, accounting for 30.53% of total market share. The report highlights that the healthcare and wound/skin care segment continues to dominate the global HOCl market, reflecting the rising importance of safe, effective, and clinically aligned antimicrobial solutions. Hypochlorous acid (HOCl) is widely positioned for wound and skin antisepsis, where its gentle tissue compatibility and non-toxic profile make it highly suitable for modern healthcare and personal care applications. This segment benefits from stronger value positioning, supported by stringent quality standards, regulatory considerations, and diversified channels across clinics, pharmacies, and branded consumer products. It is projected to grow at a CAGR of 6.6% over the forecast period. Beyond healthcare, demand for HOCl is also expanding across household and institutional settings, driven by increasing preference for low-odor, low-residue disinfecting solutions. This segment is expected to grow at a CAGR of 5.8%, supported by broader retail availability and rising hygiene awareness across homes, workplaces, and public facilities. Meanwhile, the food processing and agriculture sectors remain important contributors, with HOCl widely used in wash and process water systems. Adoption is further supported by regulatory clarity for electrolytically generated HOCl, enabling efficient, scalable, and residue-conscious sanitation in high-throughput environments. In line with these market trends, Ionic Global Sdn Bhd is strategically positioned to serve high-value application segments through its IGTECH high-purity HOCl technology. The company’s Antaviro wound care range is designed for clinical-grade wound management, addressing the dual priorities of safety and efficacy in healthcare settings. Meanwhile, the Ombac+ series extends into personal care, household, and environmental hygiene, meeting the growing demand for gentle, effective, and residue-free disinfection solutions. By integrating high-purity HOCl technology with a diversified application portfolio, Ionic Global not only aligns with evolving market dynamics but also contributes to advancing HOCl from conventional disinfection toward higher-standard medical and lifestyle applications. This strengthens the company’s position in next-generation antimicrobial innovation. As industries continue to shift toward safer and more sustainable disinfection technologies, high-purity HOCl solutions powered by IGTECH are well-positioned to meet expanding needs across healthcare, hygiene, and environmental sectors. Ionic Global Sdn Bhd plays a growing role in advancing hypochlorous acid (HOCl) solutions in Malaysia, supporting the nation’s increasing emphasis on healthcare quality, public hygiene, and sustainable disinfection practices. Leveraging its IGTECH high-purity HOCl technology, the company is positioned to bridge clinical-grade standards with everyday applications, ensuring that safe, effective, and non-toxic antimicrobial solutions are accessible across both medical and community settings. In the healthcare sector, Ionic Global’s Antaviro Wound Care range is developed to support clinical wound management with a focus on safety, efficacy, and patient comfort. Designed for use in managing acute and chronic wounds, Antaviro utilizes high-purity HOCl to help reduce microbial load while maintaining gentle tissue compatibility—an important factor in supporting healing outcomes. By aligning with modern wound care practices, Antavirocontributes to improving patient care standards in clinics, pharmacies, and home-based treatment environments. Beyond healthcare, Ionic Global extends its impact into the community through Ombac+ Instant Hygiene Spray, providing a convenient and reliable solution for everyday protection. Suitable for personal, household, and public use, Ombac+ is formulated to deliver effective disinfection with low odor and no harmful residue, making it ideal for frequent use in shared spaces. As awareness of hygiene and infection prevention continues to grow in Malaysia, Ombac+ supports a safer environment by empowering individuals and communities with practical, science-based protection. Source: Fortune Business Insights, Hypochlorous Acid Market Report (2025).